Intravenous immunoglobulin for maintenance treatment of multifocal motor neuropathy: A multi‐center, open‐label, 52‐week phase 3 trial

Intravenous immunoglobulin (IVIg) therapy is currently the only established treatment in patients with multifocal motor neuropathy (MMN), and many patients have an IVIg‐dependent fluctuation. We aimed to investigate the efficacy and safety of every 3 week IVIg (1.0 g/kg) for 52 weeks. This study was...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Peripher Nerv Syst
Главные авторы: Kuwabara, Satoshi, Misawa, Sonoko, Mori, Masahiro, Iwai, Yuta, Ochi, Kazuhide, Suzuki, Hidekazu, Nodera, Hiroyuki, Tamaoka, Akira, Iijima, Masahiro, Toda, Tatsushi, Yoshikawa, Hiroo, Kanda, Takashi, Sakamoto, Ko, Kusunoki, Susumu, Sobue, Gen, Kaji, Ryuji
Формат: Artigo
Язык:Inglês
Опубликовано: Wiley Periodicals, Inc. 2018
Предметы:
Research Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6033107/
https://ncbi.nlm.nih.gov/pubmed/29635876
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12268
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы